Prevalence and Age Distribution of Human Papillomavirus Infection in a Population of Inuit Women in Nunavik, Quebec

被引:34
作者
Hamlin-Douglas, Lauren Kay [1 ,2 ,3 ]
Coutlee, Franqois [4 ,6 ]
Roger, Michel [6 ,7 ]
Franco, Eduardo L. [1 ,2 ,3 ,4 ]
Brassard, Paul [1 ,2 ,3 ,5 ]
机构
[1] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Biostat, Montreal, PQ, Canada
[3] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada
[4] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[5] McGill Univ, Dept Med, Montreal, PQ, Canada
[6] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada
[7] Ctr Hosp Univ Montreal, Ctr Rech, Immunogenet Lab, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1158/1055-9965.EPI-08-0625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Our aim was to study the prevalence and age distribution of human papillomavirus (HPV) infection among Inuit women in Nunavik, northern Quebec, a population at high risk of cervical cancer. Methods: We recruited a cohort of Inuit women seeking routine care and living primarily in four communities of the Nunavik region. Pap smears were done and cervical specimens were tested for HPV-DNA using the PGMY-Line blot assay. Results: From January 2002 until December 2007, 629 women were recruited into the study and had their cervical specimens tested. Of 554 women with complete results, the overall and high-risk HPV prevalence were 28.9% and 20.4%, respectively. Multiple-type infections were observed in 40% of HPV-positive subjects. The most common HPV type was HPV-16 (n = 31), and other common high-risk types included HPV-31, HPV-58, and HPV-52. The most prevalent papillomavirus species were alpha-9 (60% of infections), alpha-3 (44%), and alpha-7 (31%). Age-specific prevalence of low-risk HPV, high-risk HPV, and overall HPV showed a U-shaped curve. Of women with baseline cytology, 6.5% had an abnormal result, either atypical squamous cells of undetermined significance, low-grade squamous intraepithelial lesion (LSIL), or high-grade intraepithelial lesion (HSIL). HPV-16, HPV-31, and HPV-58 were some of the most common high-risk types detected in both LSIL and HSIL specimens. Conclusions: Overall and high-risk HPV prevalence was elevated in this population of Quebec Inuit women when compared with other populations that have been studied in Canada. Different HPV types seem to be important as contributors to the overall burden of infection and to the presence of cervical abnormalities, which may have implications for developing cervical screening and vaccination programs. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3141-9)
引用
收藏
页码:3141 / 3149
页数:9
相关论文
共 35 条
[1]  
BROWN D, 2007, 47 INT C AN AG CHEM
[2]   Age-related changes of the cervix influence human papillomavirus type distribution [J].
Castle, PE ;
Jeronimo, J ;
Schiffman, M ;
Herrero, R ;
Rodríguez, AC ;
Bratti, MC ;
Hildesheim, A ;
Wacholder, S ;
Long, LR ;
Neve, L ;
Pfeiffer, R ;
Burk, RD .
CANCER RESEARCH, 2006, 66 (02) :1218-1224
[3]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[4]   Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis [J].
Clifford, GM ;
Gallus, S ;
Herrero, R ;
Muñoz, N ;
Snijders, PJF ;
Vaccarella, S ;
Anh, PTH ;
Ferreccio, C ;
Hieu, NT ;
Matos, E ;
Molano, M ;
Rajkumar, R ;
Ronco, G ;
de Sanjosé, S ;
Shin, HR ;
Sukvirach, S ;
Thomas, JO ;
Tunsakul, S ;
Meijer, CJLM ;
Franceschi, S .
LANCET, 2005, 366 (9490) :991-998
[5]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423
[6]   The immune system in the elderly II. Specific cellular immunity [J].
Ginaldi, L ;
De Martinis, M ;
D'Ostilio, A ;
Marini, L ;
Loreto, MF ;
Martorelli, V ;
Quaglino, D .
IMMUNOLOGIC RESEARCH, 1999, 20 (02) :109-115
[7]   Cervical cancer in older women: A molecular analysis of human papillomavirus types, HLA types, and p53 mutations [J].
Gostout, BS ;
Podratz, KC ;
McGovern, RH ;
Persing, DH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) :56-61
[8]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[9]   Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial [J].
Harper, DM ;
Franco, EL ;
Wheeler, CM ;
Moscicki, AB ;
Romonowski, B ;
Roteli-Martins, CM ;
Jenkins, D ;
Schuind, A ;
Clemens, SAC ;
Dubin, G .
LANCET, 2006, 367 (9518) :1247-1255
[10]   Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada [J].
Healey, SM ;
Aronson, KJ ;
Mao, Y ;
Schlecht, NF ;
Mery, LS ;
Ferenczy, A ;
Franco, EL .
SEXUALLY TRANSMITTED DISEASES, 2001, 28 (12) :694-700